A novel, blood-based test developed using fragmentomic features of cell-free DNA (cfDNA) detects colorectal cancer (CRC) with a 90.4% sensitivity and shows consistent performance across stages and ...

A Supreme Court case may jeopardize free CRC screenings, risking increased out-of-pocket costs and reversing public health progress. Biological age, rather than chronological age, may better predict ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not ...

Apple's latest phone has a lot in common with the previous model, but there are notable improvements to the camera, display and battery. Is it worth the upgrade? Abrar's interests include phones, ...